1. Home
  2. FORM vs BLTE Comparison

FORM vs BLTE Comparison

Compare FORM & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

HOLD

Current Price

$58.18

Market Cap

4.5B

Sector

Technology

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$148.41

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORM
BLTE
Founded
1993
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.1B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
FORM
BLTE
Price
$58.18
$148.41
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$51.88
$149.00
AVG Volume (30 Days)
648.0K
244.0K
Earning Date
10-29-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.53
N/A
Revenue
$759,313,000.00
N/A
Revenue This Year
$3.97
N/A
Revenue Next Year
$10.24
N/A
P/E Ratio
$110.09
N/A
Revenue Growth
2.29
N/A
52 Week Low
$22.58
$49.00
52 Week High
$61.10
$160.55

Technical Indicators

Market Signals
Indicator
FORM
BLTE
Relative Strength Index (RSI) 68.59 68.29
Support Level $56.27 $140.07
Resistance Level $54.92 $154.00
Average True Range (ATR) 2.18 12.43
MACD 0.27 0.74
Stochastic Oscillator 94.85 78.20

Price Performance

Historical Comparison
FORM
BLTE

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: